Alchemi Wealth’s Iterum Therapeutics ITRM Stock Holding History

Alchemi Wealth’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-268,886	Closed	-$90.1K	–	158
2025 Q4	$90.1K	Buy	+268,886	New	+$145K	0.05%	150

Other funds holding ITRM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

GWP

Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alchemi Wealth's ITRM Position: Q1 2026 in Review

Alchemi Wealth sold out of Iterum Therapeutics (ITRM) in Q1 2026, closing a stake of 268,886 shares — an estimated $90.1K sold.

Alchemi Wealth first reported a position in ITRM in Q4 2025 and held it in 1 quarter. The position peaked at $90.1K in Q4 2025. 18 funds tracked by Wall St. Rank hold ITRM as of Q1 2026.

Alchemi Wealth reported no remaining Iterum Therapeutics position as of Q1 2026 after selling out during the quarter.
Alchemi Wealth sold 268,886 Iterum Therapeutics shares in Q1 2026, an estimated $90.1K.
Alchemi Wealth first reported a position in Iterum Therapeutics in Q4 2025 and held it in 1 quarter.
Alchemi Wealth's Iterum Therapeutics position peaked at $90.1K in Q4 2025.
18 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2026.

Based on Alchemi Wealth's 13F filing for Q1 2026, filed 7 May 2026.